A relative of the novel coronavirus, RaTG13, has been present in bats for the past 40 to 70 years, according to new research published in Nature Biology. The Scottish study suggests that SARS-CoV-2 has likely been poised to crossover to…

A report released by the national business and technology consulting firm, West Monroe, indicates health insurers are more interested in offering dental benefits than they were two years ago.

Anthony Fauci, MD, head of the National Institute of Allergy and Infectious Diseases, recently suggested that wearing eye goggles or eye shields by everyday citizens could reduce community spread of COVID-19. He noted that the eye has…

After data demonstrated Johnson and Johnson’s (J&J) one-dose vaccine offered significant protection against COVID-19 in monkeys, the pharmaceutical giant started human trials on July 30. The initial trial includes 1,000 adults in both…

New legislation, the Continuing Small Business Recovery and Paycheck Protection Program Act, has been introduced in the Senate. Under the umbrella of the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, this would…

2C MedTech, a health care product developer and distributor specializing in commercializing real innovations with true impact, is partnering with CASPR™ Group to introduce CASPR’s next generation disinfection technology to dental offices…

Georgia School of Orthodontics (GSO) announced that it will provide four additional Atlanta-based children with complimentary orthodontic care through its Gift of a Smile program.

An experimental investigation conducted at Kansas State University’s Biosecurity Research Institute found that SARS-CoV-2 is unable to replicate in three common types of mosquitoes, making it impossible for them to transmit the virus to…

During a time of immense change, dental practices are beginning to look toward the future and how will they survive the COVID-19 pandemic. One consideration is transitioning your practice through either buying a new practice or selling your…

Moderna and Pfizer have both begun large-scale clinical trials with 30,000 participants on their respective vaccines, with the hopes of obtaining regulatory approval and widespread distribution by the end of 2020. The Moderna and Pfizer…